TSX closed
Loading markets…
Stocks/TSX-V/ZYUS

ZYUS Life Sciences Corporation (ZYUS : TSX-V)

Common Stock

$0.37

CAD

+0.02 (5.71%)

Last updated: 2026-10-28

Follow ZYUS

ZYUS

ZYUS Life Sciences Corporation

Source:WealthAwesomeWealthAwesome
↓ $0.13 (-26.00%)
30 day period
$0.35$0.55$0.75Jun 12Sep 17Oct 28

Performance

1 Day

+0.00%

1 Week

-26.00%

1 Month

-38.33%

YTD

-45.59%

Key Statistics

Market Cap

$29.79M

52W High

$0.75

52W Low

$0.30

P/E Ratio

-

50 Day MA

$0.52

200 Day MA

$0.54

Beta

0.16

Dividend Yield

-

Technical Indicators

Price vs 50-Day SMA

↓Below 50 SMA

Price vs 200-Day SMA

↓Below 200 SMA

Recent Price History

DateOpenHighLowCloseAdj CloseVolume
10/28/2026$0.38$0.38$0.37$0.37$0.373,095
10/26/2026$0.33$0.36$0.30$0.35$0.35115,415
10/15/2026$0.50$0.50$0.50$0.50$0.500
10/14/2026$0.50$0.50$0.50$0.50$0.50600
10/9/2026$0.50$0.50$0.50$0.50$0.5010,595
10/6/2026$0.60$0.60$0.60$0.60$0.600
10/2/2026$0.37$0.60$0.37$0.60$0.6022,600
10/1/2026$0.60$0.60$0.58$0.58$0.587,885
9/30/2026$0.60$0.60$0.60$0.60$0.605,122
9/28/2026$0.60$0.60$0.60$0.60$0.6019,500

Analyst Price Targets

Based on analyst covering ZYUS · as of Sep 17, 2026

📈

Wall Street analysts forecast ZYUS stock price to rise 305.4% over the next 12 months.

Consensus

Bullish

Based on avg. target vs last close (formal rating unavailable for Canadian listings)

Avg. Target

C$1.50

+305.4% Upside

Current Price

C$0.37

Last close

Compare analyst targets →

Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.

Wealth Awesome Price Forecast

WA Model

Statistical 90-day price range based on ZYUS's historical volatility

HistoricalForecast68%95%
C$0.02C$0.79C$1.55C$2.32C$3.08C$3.85TodayJan 16Apr 14Oct 28Dec 10Jan 23Mar 7

30-Day Vol

208.4%

Annualized

90-Day Vol

144.9%

Annualized

Trend (90d)

-50.0%

Annualized drift

90d Mean

C$0.31

Expected price

HorizonExpected68% Range (1σ)
30 trading daysC$0.35C$0.17 – C$0.72
60 trading daysC$0.33C$0.12 – C$0.91
90 trading daysC$0.31C$0.09 – C$1.08

Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.

About ZYUS Life Sciences Corporation

ZYUS Life Sciences Corporation manufactures and distributes cannabinoid-based therapeutics and product candidates for medical and adult recreational. The company offers Trichomylin, a softgel capsules with fixed dose combination of cannabinoids formulated that is phase 2a clinical trial for the treatment of chronic pain in adults caused due to musculoskeletal injuries, arthritis, and cancer. It operates in Canada, the United States, Australia, and the European Union. ZYUS Life Sciences Corporation was founded in 2018 and is headquartered in Saskatoon, Canada.

Financials

Revenue (TTM)
$374,000
EBITDA
$-10.09M
Profit Margin
0.00%
ROE (TTM)
-3516.83%
EPS (Diluted)
-0.25
Book Value
-0.34

Classification

Sector
Health Care
Industry
Pharmaceuticals
Group
Pharmaceuticals, Biotechnology & Life Sciences

7 stocks to buy and hold forever

Blue-chip dividend stocks for long-term wealth building.

Get the FREE Report

Common Questions About ZYUS

Market movers

Recent TSX-V movers

Top 1-day gainers — updated from our Canadian movers feed.

All movers →
TickerNamePrice1D
TNXTenX Protocols Inc.$49.89+49790.00%
CZZCleghorn Minerals Ltd$0.12+91.67%
MEGO-PAmego Capital Corp.$0.07+50.00%
SNVSonoro Energy Ltd$0.01+50.00%
ESBLEshbal Functional Food Inc.$0.07+40.00%
ALTAlturas Minerals Corp$0.02+33.33%
HANSHanstone Gold Corp$0.02+33.33%
ILCILC Critical Minerals Ltd.$0.02+33.33%

ZYUS.V news timeline

11 articles covering ZYUS.V, most recent first

Latest

Why ZYUS Life Sciences Corporation stock plummeted yesterday

•Stocks